Takeda Pharmaceutical Company today announced a $38 million grant from the Bill and Melinda Gates Foundation, part of a partnership to develop a safe, effective, and affordable Sabin-strain inactivated polio vaccine (IPV) for developing countries.
The report showed some weak spots, including a persistent and varied gap in readiness among states.
Exceptional Ebola surveillance and swift responses to outbreaks will be the key to taking advantage of the availability of Ebola vaccines, say three experts who offered their thoughts on the future use of such vaccines in a new article from the World Health Organization (WHO).
Another fatal Ebola case has been reported in Guinea's recent Ebola cluster, involving a young girl who was hospitalized at an Ebola treatment center, Reuters reported on Mar 19, citing a spokesman for the country's Ebola coordination center.
An American physician's assistant has been flown from West Africa to the United States for treatment of Lassa fever, according to recent reports from CNN and Emory University Hospital.
Some topics: weighing risks and benefits, ethical issues, and global involvement.
Canada can now be added to the growing list of countries that have detected MCR-1, the recently identified worrisome gene that disables the last-line antibiotic colistin, after it was detected in a patient and in ground beef sold in 2010, the Toronto Star reported today.
After being identified for the first time in China in November, the gene has now been confirmed in samples from at least 11 countries.
The NIH sees its biggest boost in 12 years, and other public health initiatives benefit, too.
In its annual report, TFAH said there are still major gaps and funding needed to battle new threats.
The analysis is a key part of a federal review of controversial studies on H5N1 and other pathogens.
